An Evaluation of The Pathophysiology, Prevention, and Rehabilitation Strategies for ICU-Acquired Weakness in Critically Ill Patients

Mostafa Ahmed Mohamed Tirelbar *

Critical Care Medicine, Al Qassimi Hospital – Sharjah, UAE.

Haithm Mohamed Abdelghafar Shalaby

Critical Care Medicine, Al Qassimi Hospital – Sharjah, UAE.

*Author to whom correspondence should be addressed.


Abstract

Critically ill patients are often exposed to Intensive Care Unit-Acquired Weakness (ICUAW). The pathophysiology of this condition, the preventative measures, as well as the effective rehabilitation approaches are the core for improving patient functional status and the decrease of the healthcare system burden. ICUAW is a general term that is used to include a range of neuropathies of critical importance such as preparing polyneuropathy (CIP) and critical illness myopathy (CIM), most of which can coexist during the same patient. ICUAW mechanisms can be quite subtle and complex. Several mechanisms include factors like oxidative stress, inflammation, and endothelial dysfunction. The suggested mechanisms involved are microvascular dysfunction, inflammatory responses, mitochondrial dysfunction, and neural excitation-contraction coupling failure. Nonetheless, it is fairly evident from the current data that there may be a multifactorial interplay at the basis of this illness, but the full picture continues to be obscure. The preventive strategies are targeted mostly at reducing the risk factors involved in the development of ICUAW. Strategies like early mobilization, paying due attention to the sedation strategies, and using third-generation short-acting neuromuscular blockers that can be reversed. Furthermore, technology based on electrical muscle stimulation is one of the tools being used for secondary prevention. Rehabilitation has a vital role in recovering patients from the ICUAW. The multidisciplinary approach is centered on rehabilitation development with physical therapy, occupational therapy, and respiratory therapy involvement as key elements of the overall care. Sustained exercise programs, respiratory therapy, and neuromuscular electrical stimulation are effective rehabilitation approaches in the treatment of these patients to restore muscle strength, function, and physical ability after their ICUAW. This review aims to reflect on the commonly encountered weakness in ICU patients to guide the relevant phyisicans on how to deal with them to improve the patient’s condition, even if by a small fraction.

Keywords: ICU-acquired weakness, rehabilitation, preventive strategies, poor prognosis, unfavorable outcomes


How to Cite

Tirelbar, Mostafa Ahmed Mohamed, and Haithm Mohamed Abdelghafar Shalaby. 2024. “An Evaluation of The Pathophysiology, Prevention, and Rehabilitation Strategies for ICU-Acquired Weakness in Critically Ill Patients”. Asian Journal of Medical Principles and Clinical Practice 7 (1):248-54. https://www.journalajmpcp.com/index.php/AJMPCP/article/view/230.

Downloads

Download data is not yet available.

References

Jackson M, Cairns T. Care of the critically ill patient. Surg Oxf Oxfs. 2021;39(1):29–36.

Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–53.

Leong EL, Chew CC, Ang JY, Lojikip SL, Devesahayam PR, Foong KW. The needs and experiences of critically ill patients and family members in intensive care unit of a tertiary hospital in Malaysia: A qualitative study. BMC Health Serv Res. 2023;23:627.

Patil SJ, Ambulkar R, Kulkarni AP. Patient Safety in Intensive Care Unit: What can We Do Better? Indian J Crit Care Med Peer-Rev Off Publ Indian Soc Crit Care Med. 2023;27(3):163–5.

Chang IC, Hou YH, Lu LJ, Tung YC. Self-Service System for the Family Members of ICU Patients: A Pilot Study. Healthcare. 2022;10(3):467.

Vanhorebeek I, Latronico N, Van den Berghe G. ICU-acquired weakness. Intensive Care Med. 2020;46(4):637–53.

Wang W, Xu C, Ma X, Zhang X, Xie P. Intensive care unit-acquired weakness: A review of recent progress with a look toward the future. Front Med [Internet]. 2020 [cited 2024 Apr 21];7. Available: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719824/

Lad H, Saumur TM, Herridge MS, Dos Santos CC, Mathur S, Batt J, et al. Intensive care unit-acquired weakness: Not just another muscle atrophying condition. Int J Mol Sci. 2020 Oct 22;21(21):7840.

Khalil A, Alamri RA, Aljabri GH, Shahat EA, Almughamsi RI, Almeshhen WA. A cross-sectional study of the impact of icu-acquired weakness: Prevalence, associations, and severity. Cureus. 15(12):e49852.

Guevarra K, Greenstein Y. Ultrasonography in the critical care unit. Curr Cardiol Rep. 2020;22(11):145.

Plaut T, Weiss L. Electrodiagnostic evaluation of critical illness myopathy. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Apr 22]. Available:http://www.ncbi.nlm.nih.gov/books/NBK562232/

Dangayach NS, Smith M, Claassen J. Electromyography and nerve conduction studies in critical care: step by step in the right direction. Intensive Care Med. 2016 Jul;42(7):1168–71.

Viana MV, Moraes RB, Fabbrin AR, Santos MF, Gerchman F. Assessment and treatment of hyperglycemia in critically ill patients. Rev Bras Ter Intensiva. 2014;26(1):71–6.

Brealey D, Singer M. Hyperglycemia in critical illness: A review. J Diabetes Sci Technol. 2009 Nov;3(6):1250–60.

Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology. 2005;64(8):1348–53.

Amour J, Brzezinska AK, Jager Z, Sullivan C, Weihrauch D, Du J, et al. Hyperglycemia adversely modulates endothelial nitric oxide synthase during anesthetic preconditioning through tetrahydrobiopterin- and heat shock protein 90-mediated mechanisms. Anesthesiology. 2010;112(3):576–85.

Huang M, Cai S, Su J. The pathogenesis of sepsis and potential therapeutic targets. Int J Mol Sci. 2019;20(21):5376.

Yang T, Li Z, Jiang L, Wang Y, Xi X. Risk factors for intensive care unit-acquired weakness: A systematic review and meta-analysis. Acta Neurol Scand. 2018;138(2):104–14.

Mallinson JE, Murton AJ. Mechanisms responsible for disuse muscle atrophy: potential role of protein provision and exercise as countermeasures. Nutr Burbank Los Angel Cty Calif. 2013;29(1):22–8.

Anekwe DE, Biswas S, Bussières A, Spahija J. Early rehabilitation reduces the likelihood of developing intensive care unit-acquired weakness: A systematic review and meta-analysis. Physiotherapy. 2020;107:1–10.

Schefold JC, Bierbrauer J, Weber-Carstens S. Intensive care unit-acquired weakness (ICUAW) and muscle wasting in critically ill patients with severe sepsis and septic shock. J Cachexia Sarcopenia Muscle. 2010; 1(2):147–57.

Adeyinka A, Layer DA. Neuromuscular Blocking Agents. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Apr 22]. Available: http://www.ncbi.nlm.nih.gov/books/NBK537168/

Brunello AG, Haenggi M, Wigger O, Porta F, Takala J, Jakob SM. Usefulness of a clinical diagnosis of ICU-acquired paresis to predict outcome in patients with SIRS and acute respiratory failure. Intensive Care Med. 2010;36(1):66–74.

Murray MJ, DeBlock H, Erstad B, Gray A, Jacobi J, Jordan C, et al. Clinical practice guidelines for sustained neuromuscular blockade in the adult critically ill patient. Crit Care Med. 2016;44(11):2079–103.

Rodríguez-Blanco J, Rodríguez-Yanez T, Rodríguez-Blanco JD, Almanza-Hurtado AJ, Martínez-Ávila MC, Borré-Naranjo D, et al. Neuromuscular blocking agents in the intensive care unit. J Int Med Res. 2022;50(9):03000605221128148.

Wang YT, Lang JK, Haines KJ, Skinner EH, Haines TP. Physical Rehabilitation in the ICU: A Systematic Review and Meta-Analysis. Crit Care Med. 2022;50(3):375–88.

Khalil A, Alamri RA, Aljabri GH, Shahat EA, Almughamsi RI, Almeshhen WA. A cross-sectional study of the impact of ICU-acquired weakness: Prevalence, associations, and severity. Cureus. 15(12):e49852.

Wappel S, Tran DH, Wells CL, Verceles AC. The effect of high protein and mobility-based rehabilitation on clinical outcomes in survivors of critical illness. Respir Care. 2021;66(1):73–8.

Choi J, Tasota FJ, Hoffman LA. Mobility interventions to improve outcomes in patients undergoing prolonged mechanical ventilation: A review of the literature. Biol Res Nurs. 2008;10(1):21–33.

Lippi L, de Sire A, D’Abrosca F, Polla B, Marotta N, Castello LM, et al. Efficacy of physiotherapy interventions on weaning in mechanically ventilated critically ill patients: A systematic review and meta-analysis. Front Med. 2022;9:889218.

Huang J, Qiao X, Song K, Liu R, Huang S, He J, et al. Effectiveness of rehabilitation interventions in individuals with emerging virtual respiratory tract infectious disease: A Systematic review and meta-analysis. Clin Rehabil. 2024;02692155241239881.

Munoz-Price LS. Long-term acute care hospitals. Clin Infect Dis Off Publ Infect Dis Soc Am. 2009;49(3):438–43.

Lee BY, Bartsch SM, Lin MY, Asti L, Welling J, Mueller LE, et al. How long-term acute care hospitals can play an important role in controlling carbapenem-resistant enterobacteriaceae in a region: A simulation modeling study. Am J Epidemiol. 2020;190(3):448–58.